References:
Masquelier,
J. Plant extract with a proanthocyanidins content as a therapeutic agent having
radical scavenging effect and use thereof. U.S. Patent No. 4,698,360, 1987.
Masquelier, J. A lifetime devoted to OPC and Pycnogenols. Alfa Omega Editrice,
Pub., 1996.
Schwitters, B., Masquelier, J. OPC in practice. Alfa Omega Editrice,
Publishers, 1995.
Lombard, J., Germano, C. The brain wellness plan: breakthrough
medical, nutritional and immune-boosting therapies to prevent and treat: depression,
Alzheimer's disease, chronic fatigue syndrome, attention deficit disorder, multiple
sclerosis, Parkinson's disease, Lou Gehrig's disease. Kensington Pub. Corp., 1998.
Kilham, C., Masquelier, J. OPC: The miracle antioxidant. Keats Publishing,
Inc., 1997.
Packer, L., et al. The antioxidant miracle: your complete plan.
John Wiley & Sons, Inc., 1999.
Packer, L., et al. Antioxidant food supplements
in human health. Academic Press, 1999.
Lincoln, J., Hoyle, C.H.V., Burnstock,
G., Nitric oxide in health and disease. Cambridge University Press, 1997.
Moncada, S., Nistico, G., Bagetta, G., Higgs, E.A. Nitric oxide and the cell.
Princeton University Press, 1998.
Facino, R.M., et al. Free radical scavenging
action and anti-enzyme activities of procyanidines from vitis vinifera. A mechanism
for their capillary protective action. Arzneimittelforschung, 44: 592-601, 1994.
Passwater, R.A. The antioxidants: the nutrients that guard your body. Keats
Publishing, Inc., 1985.
Barilla, J. et al. The nutrition superbook: volume
1: the antioxidants. Keats Publishing, Inc., 1995.
Facino RM, et al. Free radical scavenging action and anti-enzyme activities of
procyanidines from Vitis vinifera. A mechanism for their capillary protective
action. Arzneimittelforschung, 44: 592-601, 1994.
Kuttan R, et al. Collagen
treated with catechin becomes resistant to the action of mammalian collagenase.
Experientia, 37: 221-223, 1981.
Masquelier, J., et al. Stabilization du collagene
par les oligomeres procyanidoliques. Acta Therapeutica, 7:101-105, 1981.
Masquelier,
J. Aspects pharmacologiques nouveaux de certains flavonoides. A Vie Medical 12:1969.
Laparra, J., et al. Etude pharmaco-cinetique des oligomers procyandoliques totaux
du raisin. Acta Therapeutica, 4, 1978.
Laparra, J., et al. Etude pharmacocinetique
des oligomeres flavonoliques. Plantes med et phyto, Tome XI, pp. 133-142, 1977.
Robert A.M.; Groult, N.; Six, C.; Robert, L. Etude de l’action des oligomeres
procyanidoliques sur des cellules mesenchymateuses en culture. Ii l’attachment
des fibres elastiques aux cellules. (Study of the effect of procyanidolic oligomers
on mesenchymal cells in culture. Ii attachment of elastic fibers to the cells.)
Pat Biol, (30)6:601-7, 1990.
Porter, Lawrence J., Wong Rosalind Y. Chan, Bock
G. The molecular and crystal structure of (+)-2,3-trans-3,4-trans-leucocyanidin
[(2r,3s,+r)-(+)-3,3’, 4.4’, 5.7’-Hexahydroxyflavan] dihydrate,
and comparison of its heterocyclic ring conformation in solution and the solid
state. Journal of the Chemical Society; Perkin Transactions I 1985. pp. 1413-17.
Masquelier, J. Proanthocyanidins et radicaux libres. 1985.
Uchida, S., et
al. Condensed tannins scavenge active oxygen free radicals. Med Sci Res, (15)
1987. pp. 831-832.
Ariga, T. Radical scavenging action and its mode in procyanidins
b-1 and b-3 from azuki beans to peroxyl radicals. Agric Biol Chem, 54(10) 1990.
pp. 2499-2504.
Da Silva, R., et. al. Radical scavenger capacity of different
procyanidins from grape seeds. Presented at a symposium, “Free radicals in
biotechnology and medicine.” Royal Society Of Chemistry, London January 1990,
pp. 79-80.
Bauman, J., Wurm, G., Bruchhausen, F. “Hemmung der prostagladinsynthetase
durch flavonoide und phenolderivate im vergleich nit deren 02 radikalfangereigenschaften”
Arch Pharm, (Weinheim) 313 (1980) pp. 330-337.
Flesch M., et al., Effects
of red and white wine on endothelium-dependent vasorelaxation of rat aorta and
human coronary arteries. Am J Physiol 1998;275:1183-94.
Fitzpatrick, D.F.,
Fleming R.C., Bing B, Maggi DA, O'Malley RM. Isolation and characterization of
endothelium-dependent vasorelaxing compounds from grape seeds. J Agr & Food
Chem In press.
Fitzpatrick, D.F., Maggi D, Bing B, Coffey RG. Vasorelaxation,
endothelium, and wine. BioFactors 1997;6:455-459.
Fitzpatrick, D.F., Hirschfield
SL, Ricci T, Jantzen P, Coffey RG. Endothelium-dependent vasorelaxation caused
by various plant extracts. J Cardiovasc Pharmacol 1995;26:90-95.
Fitzpatrick,
D.F., Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing activity of
wine and other grape products. Amer J Physiol 1993;265:H774-H778.
Kuttan,
R., Donnelly, P.V., Di Ferrante, N. Collagen treated with catechin becomes resistant
to the action of mammalian collagenase. Experientia, 37: 221-223, 1981.
Masquelier,
J. Procyanidolic oligomers. J Parums Cosm Arom, 95: 89-97, 1990.
Tixier,
J.M., et al. Evidence by in vivo and in vitro studies that binding of pycnogenols
to elastin affects its rate of degradation by elastases. Biochem Pharmacol, 33:
3933-3939, 1984.
Kakegawa, H., et al. Chem. Pharm. Bull. 33:5079, 1985.
Harmand, M.F., Blanquet, P. The fate of total flavanolic oligomers extracted from
‘vitus vinifera l.’ in the rat. European Journal of Drug Metabolism
and Pharmaccokinetics. 1978, No. 1 pp. 15-30.
Delrieu, P., Ding J., Escande,
B., Samain, D. Free-radical scavenging activity of proanthocyanidolic oligomers
encapsulated in glycospheres: an in vivo and in vitro study. Cosmetology Department
& S Biovectors, Ramonville St. Agne France. pp. 1-9.
Meunier, M.T., Villie,
F., et al. Inhibition of angiotensin i converting enzyme by flavanolic compounds:
in vitro and in vivo studies. Planta Medica, May 26, 1986. pp. 12-15.
Barbier,
A., et al. Activite angioprotectrice des oligomeres procyanidolques chez l’animal-oedenme
de la patte. Sanofi Res Toul Cedex Fr, pp31-40.
Barbier, A., et al. Activite
angioprotectrice des oligomeres procyanidolques chez l’animal-activite aniagoniste
vis-a-vis des mediateurs de l’inflamation. Sanofi Res Toul Cedex Fr, pp.
31-40.
Dubos, C., Durst, G., Hugonot, H. Evolution de la resistance capillaire,
spontanement ou artificiellement diminuee par l’action d’une substance
capillaro-toxique chez des personnes agees--action benefique d’un agnet actif
sur la micro-circulation: l’Endotelon. Inform. Therapeut. 1980. pp. 302-305.
Dartenuc, J.Y., et al. Resistance capillaire en geriatrie etude d’un microangioprotecteur-Endotelon.
Bordeaux Med. 13:903-7, 1990.
Lagrue, G., Olivier-Martin, F., Grillot, A.
“Etude des effets des oligomeres du procyanidol sur las resistance capillaire
dand l’hypertension arterielle et certaines nephropathies.” Sen. Hosp.
Paris 18-25 Septembre, 1981.
Beylot, C., Bioulac, P. Essai therapeutique d’un
angioprotecteur peripherique, l’Endotelon. Actualite Therapeutique Gaz. Med.
de France (87)22:2919-24, 1980.
Lesbre, F.X., Tigaud, J.D. Effect de l’Endotelon
sur l’indice de fragilite capillaire dan une population specifique: les sujets
cirrhotiques. Gaz. Med. de France, (90)24 1983.
Sarrat, L. Abord therapeutique
des troubles fonctionnels des membres inferieurs par un microangioprotecteur l’Endotelon.
Bordeaux Med, 11:685-8, 1981.
Delacroix, P. Etude en double aveugle de l’Endotelon
dans l’insuffisance veineuse chronique. Therapeutique, la Revue de Medicine,
(27-28) Sept. 1981. pp. 1793-1802.
Thebaut, J.F, Thebaut, P., Vin, F. Etude
de l’Endotelon dand les manifestations fonctionnelles de l’insuffisance
veineuse peripherique-resultats d’une etude en double aveugle portant sur
92 patients.” Gazette Medicale, (92)1, 1985. pp. 96-100.
Wegrowski, J.,
Robert, A.M., Maczar, M. The effect of procyanidolic oligomers on the composition
of normal and hypercholesterolemic rabbit aortas. Biochem. Pharmacol, (33)21.
1984. pp. 3491-3497.
Chang, W.C., Hsu, F.L. Inhibition of platelet aggregation
and arachidonate metabolism in platelets by procyanidins. Prostagland Leukotri
Essent Fatty Acids, 38:181-8, 1989.
Masquelier, J. Pycnogenols: recent advances
in the therapeutical activity of procyanidins. Supplement of Planta Medica, Journal
of Medicinal Plant Research and Journal of Natural Products, July 1980 pp. 243-256.
Henning, B., et al. Lipid peroxidation and endothelial cell injury: implications
in atherosclerosis. Free Rad Path & Med, (4)1988 pp. 99-106.
Masquelier,
J. “Les procyanidols du vin leur role dans l’alcoolisme.” pp. 88-93.
Gazave, J.M. “Notions recentes sur les capillaires” unpub. bulletin
from the Laboratoire De Physiologie Patholigie pp. 26-29.
Ruf, J.C. Wine and
polyphenols related to platelet aggregation and atherothrombosis. Office International
Vigne et du Vin, Nutrition and Health Unit, Paris France; Drugs under Experimental
and Clinical Research (Switz.) 25/2-3 (125-131), 1999.
Blaszo, G. Gabor, M.
Oedema-inhibiting effect of procyanidin. Acta Physiologica Academiae Scientiarum
Hungaricae, Tomus 56(2):235-240, 1980.
Tayau, M.F, LeFevre, G. Action du leucocyanidol
sur l’hyalaluronidase. Bull Soc Pharm Bordeaux, 95:132-136, 1956.
Lamy,
M. Utilization des oligomeres procyanidoliques en gynecologie. Essai Therapeutique
Tomel (14) Sept. 2, 1981. pp. 1021-22.
Henriet, J.P “Une Etude Exemplaire
Pour Un Phlebotrope: l’etude EIVE.’ Unpub., pp. 77-83.
Pfister,
A., Simon, M.T., Gazave, J.M. Sites de fixation des oligomeres procyanidoliques
dans la paroi des capillaires sanguins du poumon decobaye. Acta Therapeutica (8)
1982. pp. 223-237.
Kuttan, R., Donnelly, P., Di Ferrante, N. “Collagen
treated with (+) -catechin becomes resistant to the action of mammalian collagenase.”
Laboratory of Connective Tissue Research, Dept. of Biochem. Baylor Col. of Med.,
Houston TX. 28, May, 1980.
Gendre, P., Laparra, J., Barraud, E. “Effect
protecteur des oligomeres procyanidoliques sur le lathyrisme experimental chez
le rat.” Ann. Pharm. Francaises, (43)1, 1985 pp. 61-73.
Corbe, C., Boissin,
J.P., Siou, A. Light vision and chorioretinal circulation. Study of the effect
of procyanidolic oligomer (Endotelon). Jn. Fr. Opthalmol, (11)5:453-460, 1988.
Boissin, J.P., Corbe C., Siou, A. Chorioretinal circulation and dazzling: use
of procyanidol oligomers (Endotelon). Bull Soc Ophtalmol Fr, 88(2):173-4, 177-9,
1988.
Proto, F. et al. Electrophysical study of vitis vinifera procyanoside
oligomers effects on retinal function in myopic subjects. Ann Ott Clin Ocul, 114:85-93,
1988.
Saracco, J.B., Estachy, G.M. Etude d l’Endotelon en opthalmologie.
Gaz Med de France, 88:2035-2038, 1981.
Scharrer, A., Ober, M. Anthocyanosides
in the treatment of retinopathies. Klin Monatsbl Augenheilkd, 178:386-389, 1981.
Corbe, C., et al. Microangiopathy of the retina. J. Fr. Opthalmol, 11:453, 1988.
Verin, M.M., Vildy, A., Maurin, J.F., Retinopathies et O.P.C. Bordeaux Medicale,
(16)11. pp. 1467-74, 1978.
Soyeux, A. et al. Endotelon. Diabetic retinopathy
and hemorheology. Bull Soc Ophtalmol Fr. 87(12):1441-4, 1987.
Fromantin, M.
“Les oligomeres procyanidoliques dans le traitement de la fragilite capillaire
et de la retinopathie chez les diabetiques. A propos de 26 cas.” Med Int,
16(11):432-434, Nov. 1981.
Arne, J.L. Contribution a l’etude des oligomeres
procyanidoliques: Endotelon, dans la retinopathie diabetique (a propos de 30 observations).
Gaz. Med. de France, Vol. 89, No. 30, Oct. 8, 1982.
Baruch, J. Effect of Endotelon
in postoperative edema. Results of a double-blind study versus placebo in 32 female
patients. Ann Chir Plast Esthet 29(4):393-5, 1984.
Rao, C.N. et al. Influence
of bioflavonoids on the collagen metabolism in rats with adjuvantinduced arthritis.
Ital J Biochem. 30:54-62, 1981.
Gabor, M. Pharmacologic effects of flavonoids
on blood vessels. Angiologica, 9:355-374, 1972.
Havsteen, B. Flavonoids, a
class of natural products of high pharmacological potency. Biochem Pharmacol,
32:1141-48, 1983.
Reimann, H.J., Lorenz, W., Fischer, M., Frölich, R.,
Meyer, H.J. Berkhauser Verlag, Vol. 7/1, Univ. of Marburg/Lahn, Ger., 1977.
Masquelier, J. Action protectrice du vin sur l’ulcere gastrique. Resultats,
p. 61.
Amella, M., et al. Inhibition of mast cell histamine release by flavonoids
and bioflavonoids. Planta Medica, 5116-20, 1985.
Shaw, R. How [Australian]
PycnoGenol [MASQUELIER’s®] Helps Sports People.
Masquelier, J. Procyanidolic
oligomers (leucocyanidins). Parfums Cosmet Arom 95:89-97, 1990.
Pecking, A.,
Desprez-Curely, J.P., Megret, G. Oligomers procyanidoliques (Endotelon) dans le
traitement des lymphoedemes post-therepeutiques de members superieurs. Symposium
Satellite, Congres International d’Angiologie, Toulouse, France, 4-7 Oct.
1989.
When
we are under stress, our adrenaline flows and causes our blood vessels to constrict,
increasing blood pressure, and blood platelets are activated—prepared to
clump together to form a clot. This "fight or flight response" is appropriate
in short-term dangerous situations. The blood platelets are prepared for an injury
to more quickly form a blood clot and more efficiently prevent blood loss.
Aspirin
is widely prescribed by doctors to prevent heart attacks because of its ability
to inhibit platelet aggregation by inhibiting the enzyme cyclooxygenase. However,
Flavay ™ works differently. Flavay ™ supports the body's own production
of nitric oxide—helping the body to produce adequate levels and thereby
causing the blood platelets to return to their normal, smooth condition.
"[A]
method for preventing and fighting the harmful biological effects of free
radicals in the organism of warm blooded animals and more especially human
beings, namely cerebral involution, hypoxia following atherosclerosis, cardiac
or cerebral infarction, tumour promotion, inflammation, ischaemia, alterations
of the synovial liquid, collagen degradation, among others. The method consists
in administering to said animals and especially to human beings an amount, efficient
against said effects, of a plant extract with a proanthocyanidins content which
has a radical scavenger effect"—Dr. Jack Masquelier, U.S.
Patent No. 4,698,360.
Flavay
™ is the product—used in the actual experiments—by which Dr. Jack
Masquelier established and patented the "radical scavenger effect."
Flavay
™ has been sold world-wide for cardiovascular health and extensively tested
in humans for more than 50 years. The vascular protective activity of Flavay ™
has been established by many significant studies, demonstrating several important
ways in which Flavay ™ may mitigate the risk of heart attack and stroke.
CLICK
ON BUTTON TO RECEIVE A FREE 
